Mr. Tianhao Zou | Cancer Immunotherapy | Best Researcher Award
Tongji Medical College Huazhong University of Science and Technology | China
Author Profile
πDr. Tianhao Zou: A Rising Star in Hepatobiliary Oncology π
Full Name: Tianhao Zou
Gender: Male
Designation: Resident Physician
Department: Department of Hepatobiliary Surgery, Center for Liver Transplantation
Institution/Organization: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Qualification: Doctor
Area of Specialization: Hepatobiliary Oncology and Cancer
Sub Division: Oncology Therapeutics and Novel Approaches
DOB: September 10, 1997
DOJ: July 01, 2021
Total Experience: Doctor for 1 year, Master for 3 years, Bachelor for 5 years
Mobile Number: +86 18162279089
Email: zoutianhao@126.co
π Education:
- 2015-2020: Bachelor of Clinical Medicine, School of Medicine of Nanchang University.
- 2020-2023: Master of Surgery, Tongji Medical College, Huazhong University of Science and Technology.
- 2023-present: Doctor of Surgery, Tongji Medical College, Huazhong University of Science and Technology.
π¬ Experience:
- July 2021 to present: Resident Physician, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.
π Research, Innovations, and Extensions:
- No. of Research Projects Completed and Ongoing: 6
- Citation Index: 61
- Consultancy and Industry Sponsored Projects: 0
- Books Published with ISBN: 0
- Total Cost of Projects: $414,000 USD
- Patents Published and Under Process: 5
- Journals Published in SCI and SCIE Index: 12
- Editorial Appointments in Journals/Conferences: 2
- Journals Published in Scopus, Web of Science, and PubMed Index: 13
- Countries Visited for Research Activities: 1
- Journals Published in Other Index: 4
- Research Scholars Graduated: 0
- Conference Presentations: 0
- Research Scholars Ongoing: 0
- Cumulative Impact Factor (Last 3 Years): 55
- Invited Speaker/Resource Person: 1
- H-index: 5
- Research Conferences/Workshops Organized: 0
- Collaborative Activities for Research: 0
- Awards and Recognition Received: 1
- Functional MoUs with Other Universities/Industries/Corporates: 0
- Membership in Professional Bodies: 10
π Areas of Research:
- Oncology Therapeutics and Novel Approaches
Contributions to Research & Development, Innovations, and Extension Activities:
Dr. Tianhao Zou has made substantial contributions to the field of tumor research, particularly focusing on hepatobiliary malignancies. His active participation in research projects has significantly advanced the understanding of tumor biology, therapeutic interventions, and patient care outcomes. By collaborating with interdisciplinary teams, Dr. Zou has identified novel biomarkers, therapeutic targets, and treatment modalities aimed at improving patient outcomes and quality of life.
In his innovative efforts, Dr. Zou has played a pivotal role in translating research findings into clinical practice. His collaborations with industry stakeholders, academic institutions, and healthcare providers have facilitated the development and implementation of cutting-edge technologies and treatment approaches in oncology.
Beyond his research endeavors, Dr. Zou is committed to extension activities that promote cancer prevention, early detection, and treatment within the community. Through educational workshops, public seminars, and outreach programs, he empowers patients, caregivers, and healthcare professionals with essential information and resources to combat cancer effectively. Dr. Zou’s dedication to advancing cancer research, innovation, and community outreach underscores his commitment to making a meaningful impact in the fight against cancer.
π Proof Links:
Institute ID: D202382031
Certificate (Education Proof of Last Degree): 1048732023102672
Passport/Govt. ID (Age Proof): 360425199709100212
ποΈSuitable Award Categories:
- Distinguished Scientist Award
- Young Scientist Award
- Lifetime Achievement Award
- Outstanding Scientist Award
- Women Research Award
- Best Researcher Award
- Best Innovation Award
- Best Faculty Award
- Best Research Scholar Award
- Excellence in Innovation
- Excellence in Research
- Excellence Award (Any Scientific Field)
- Best Research/Innovation Extension Activity
πβοΈDeclaration:
I authenticate that to the best of my knowledge, the information given in this form is correct and complete. At any time I am found to have concealed any material information, my application shall be liable to be summarily terminated without notice. I have read the terms and conditions and other policies of the International Research Awards and agree to stand by the same. I agree to Pencis to process the data submitted in this application form, or any other data that the Foundation may obtain from me for any purposes connected with Pencis for any other legitimate reason.
ππ¬Notable Publication:
- Title: Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma
- Authors: Xu, J.; Zheng, Q.; Cheng, X.; Yi, X.; Gao, Y.
- Journal: Journal of Nanobiotechnology
- Volume: 19
- Issue: 1
- Pages: 355
- Year: 2021
- Title: High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma
- Authors: Xu, J.; Su, Z.; Cheng, X.; Gao, Y.; Zheng, Q.
- Journal: Cancer Cell International
- Volume: 22
- Issue: 1
- Pages: 115
- Year: 2022
- Title: Cell therapy for neuropathic pain
- Authors: Yin, Q.; Zou, T.; Sun, S.; Yang, D.
- Journal: Frontiers in Molecular Neuroscience
- Volume: 16
- Pages: 1119223
- Year: 2023
- Title: Light-triggered polymeric prodrug and nano-assembly for chemo-photodynamic therapy and potentiate immune checkpoint blockade immunotherapy for hepatocellular carcinoma
- Authors: Gao, Y.; Su, Z.; Wang, C.; Yi, X.; Zheng, Q.
- Journal: Materials and Design
- Volume: 225
- Pages: 111457
- Year: 2023
- Title: A NRF2 Regulated and the Immunosuppressive Microenvironment Reversed Nanoplatform for Cholangiocarcinoma Photodynamic-Gas Therapy
- Authors: Wang, W.; Gao, Y.; Xu, J.; Xia, Y.; Zheng, Q.
- Journal: Advanced Science
- Volume: 11
- Issue: 14
- Pages: 2307143
- Year: 2024